Picture of Achieve Life Sciences logo

QUIT — Achieve Life Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Achieve Life Sciences Inc reports results for the quarter ended in March - Earnings Summary

* Achieve Life Sciences Inc  ACHV.OQ  reported a quarterly
adjusted loss of 50 cents​​ per share for the quarter ended in
March. The mean expectation of five analysts for the quarter was
for a loss of 69 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Achieve Life Sciences Inc's reported EPS for the quarter
was a
loss of 50 cents​.
    * The mean earnings estimate of analysts had risen by
about 18.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Achieve Life Sciences Inc shares had risen by 28.5% this
quarter and gained 256.7% so far this year.
    * The company reported a quarterly loss of $8.99 million.
    * Wall Street's median 12-month price target for Achieve
Life
Sciences Inc is $22.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
9 at 10:34 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.69          -0.50          Beat
 Dec. 31 2022      -0.83          -0.83          Met
 Sep. 30 2022      -1.13          -1.35          Missed
 Jun. 30 2022      -0.83          -1.08          Missed

Recent news on Achieve Life Sciences

See all news